肝硬化患者急性肾损伤后慢性肾病常见且损害临床结局
该研究纳入409例肝硬化住院患者(168例发生急性肾损伤AKI,241例未发生),评估AKI后3个月慢性肾病(CKD)的发生率及其对结局的影响。结果显示AKI存活者中25%在3个月时发生CKD,而无AKI者仅1%(OR 31,p<0.0001),且CKD与3个月再入院率增加及多种肝硬化并发症相关,但无移植生存率未受损。
要点
- 肝硬化患者AKI后3个月CKD发生率为25%,显著高于无AKI者的1%。
- 院内获得的AKI及AKI严重程度(≥1B期)是CKD的独立危险因素。
- AKI向CKD转化与3个月再入院率增加及并发症增多相关,应视为高危状态。
核心结论
- 肝硬化患者AKI存活后常发生CKD,并对再入院率及并发症等临床结局产生负面影响。
研究设计与样本
- 研究在6.5年期间连续纳入因肝硬化并发症住院的患者,按同一方案定期评估肾功能。
- 共纳入409例患者,其中168例发生AKI,241例未发生AKI。
- CKD定义为AKI后3个月时估算肾小球滤过率(eGFR)<60 ml/min/1.73m2。
主要发现
- 3个月时AKI组97例存活者中24例发生CKD,而无AKI组188例存活者中仅2例发生CKD(25% vs. 1%,OR 31,p<0.0001)。
- 与CKD独立相关的危险因素为院内获得性AKI和AKI严重程度(≥1B期)。
- 诊断CKD时所有患者均为CKD 3A期,其中四分之一在1年后进展至3B期和4期。
- AKI向CKD转化与3个月再入院率增加、AKI复发、细菌感染、腹水及难治性腹水频率增加相关,并有肝移植需求增加的趋势。
- 无移植生存率未受损。
关键数值与推荐
- CKD判定标准为AKI后3个月时eGFR<60 ml/min/1.73m2。
- AKI后3个月CKD发生率为25%,无AKI者为1%(OR 31,p<0.0001)。
- 诊断CKD时均为3A期,四分之一在1年后进展至3B期和4期。
临床怎么用
- 对肝硬化AKI存活者应在3个月时评估eGFR以筛查CKD。
- 院内获得性或严重AKI(≥1B期)患者应视为CKD高危人群加强随访。
- 发生AKI后CKD者需关注再入院、感染、腹水等并发症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Acute kidney injury (AKI) is common in cirrhosis and is associated with poor prognosis. In patients who survive after AKI, it is not known whether the acute injury leads to chronic impairment of kidney function (chronic kidney disease [CKD]). The aim of the study was to determine the frequency of CKD at 3 months after an AKI episode and its effects on patient outcomes. METHODS: Patients admitted for complications of cirrhosis during a 6.5-year period were evaluated using the same protocol, with assessment of kidney function at regular intervals during and after hospitalization. CKD was defined as estimated glomerular filtration rate (eGFR) <60 ml/min/1.73m2 at 3 months after AKI. RESULTS: A total of 409 patients (168 with AKI and 241 without AKI) were included. After 3 months, 97 patients with AKI and 188 patients without AKI had survived. Of the 97 patients with AKI, 24 had developed CKD at 3 months compared to only 2 of the 188 patients without AKI (25% vs. 1%, odds ratio 31; p <0.0001). Risk factors independently associated with CKD were nosocomial AKI and severity of AKI (stage ≥1B). At diagnosis of CKD, all patients had stage 3A CKD and one-quarter of them progressed to stages 3B and 4 after 1 year. The transition from AKI to CKD was associated with an increased rate of 3-month hospital readmission, increased frequency of AKI, bacterial infections, ascites, and refractory ascites and a trend towards a higher need for liver transplantation. Transplant-free survival was not impaired. CONCLUSIONS: CKD frequently develops in patients with cirrhosis who survive AKI and has a negative impact on relevant clinical outcomes. The transition from AKI to CKD is common and should be considered a high-risk condition in patients with cirrhosis. LAY SUMMARY: Episodes of acute impairment of kidney function are common in patients with cirrhosis. This study shows that the development of chronic impairment of kidney function is frequent in patients surviving these acute episodes and that it is associated with a higher risk of developing other complications of cirrhosis and to a higher rate of 3-month hospital readmissions.
引用
- Bassegoda O, Huelin P, Ariza X, et al. Development of chronic kidney disease after acute kidney injury in patients with cirrhosis is common and impairs clinical outcomes. J Hepatol. 2020. PMID: 31953138. doi:10.1016/j.jhep.2019.12.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。